Compare DexCom, Inc. (DXCM) vs iShares 0 3 Month Treasury Bond ETF (SGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs iShares 0 3 Month Treasury Bond ETF — how do they compare? DexCom, Inc. trades at $77.2 (market cap $28.06B), while iShares 0 3 Month Treasury Bond ETF trades at $100.54. Which is the better fit depends on your goals.
| DXCM | SGOV | |
|---|---|---|
Market Cap | $28.06B | — |
Sector | Health | Fixed Income |
52-Week High | $89.53 | $100.74 |
52-Week Low | $54.84 | $100.28 |
Enterprise Value | $27.03B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
SGOV, the iShares 0-3 Month Treasury Bond ETF, trades at $100.545, up 0.02% over 24 hours, with technical indicators showing a bullish trend from moving averages but mixed signals from oscillators. The ETF offers a low-risk cash alternative with a yield around 3.5–3.65% and minimal expense ratio of 0.09%, attracting significant investor inflows amid rate uncertainty. Recent news highlights its role in diversification and income strategies for conservative portfolios.
Outlook remains positive for SGOV as a safe-haven asset, benefiting from Federal Reserve policy speculation and demand for short-term yield. Risks include interest rate volatility and competition from similar ETFs. Wall Street sentiment is favorable, with analysts endorsing its cost efficiency and liquidity for cash management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About iShares 0 3 Month Treasury Bond ETF
SGOV provides exposure to ultra-short-term U.S. Treasury bills with maturities of three months or less. It functions as a high-liquidity cash alternative, seeking to provide current income while maintaining a stable net asset value and minimal interest rate risk.
Read more on SGOV →
